鲑鱼降钙素联合金天格胶囊治疗老年性骨质疏松症的临床观察
Clinical observation of salmon calcitonin combined with Jintiange capsules in the treatment of senile osteoporosis
  
DOI:10.3969/j.issn.1006-7108.2014.06.019
中文关键词:  鲑鱼降钙素  金天格胶囊  骨质疏松
英文关键词:Salmon calcitonin  Jintiange capsules  Osteoporosis
基金项目:
作者单位
张学昌 黄洪* 储辉 张传飞 解放军第100医院微创骨科江苏 苏州 215007 
摘要点击次数: 1012
全文下载次数: 971
中文摘要:
      目的 观察鲑鱼降钙素联合金天格胶囊治疗老年性骨质疏松症的临床疗效。方法 将46例骨质疏松的患者随机分为治疗组和对照组,每组23例,治疗组采用鲑鱼降钙素联合金天格胶囊治疗骨质疏松,连续3个月为1疗程,对照组单独采用鲑鱼降钙素肌肉注射治疗骨质疏松,连续3个月为1疗程;评价治疗前后的疼痛缓解情况和腰椎骨密度(BMD)变化。结果 对照治疗2个疗程后总有效率与对照组比较差异有统计学意义(P<0.05)。结论 鲑鱼降钙素联合金天格胶囊治疗老年性骨质疏松症有效提高骨密度,缓解临床症状。
英文摘要:
      Objective To observe the clinical efficacy of salmon calcitonin combined with Jintiange capsules in the treatment of senile osteoporosis. Methods Forty-six patients with osteoporosis were randomly divided into the observation group and the control group, with 23 cases in each group. Patients in the control group were treated with the intramuscular injection of salmon calcitonin only. Patients in the observation group were treated with salmon calcitonin combined with Jintiange capsules. A consecutive 3-month treatment was considered as one treatment course. The pain relief and the changes of the lumbar bone mineral density (BMD) were evaluated. Results After two-course treatment, the total efficient rate in the observation group was significantly different compared with that in the control group (P<0.05). Conclusion Salmon calcitonin combined with Jintiange capsules can effectively improve BMD and relieve clinical symptoms in patients with senile osteoporosis.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=3C06DB566315F8DCEE2AF20477E2299008C6CFBF09D6B2F6C8805D3CD5442477DD995A90A11CE421DAF8CA74F05B6626F25EB2D8AD157A298234F7C7DC6921EEE53B23FA5589CA4B39519CCA5F58D1DDF213C74C76AF58B9BE94BF6D9F3C73491964EA3C78954BE367AC30FBE11B9A5C74A90648D2E948C4&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=9EAD63ADE6B277ED&aid=5998CFCADEB2AE4AAD9DC5A0C7E0C5BE&vid=&iid=B31275AF3241DB2D&sid=B28C697BC3A1BA62&eid=DEE640F0CDC9D495&fileno=20140619&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="9EAD63ADE6B277ED"; var my_aid="5998CFCADEB2AE4AAD9DC5A0C7E0C5BE";